243 related articles for article (PubMed ID: 20008199)
41. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.
Girelli D; Trombini P; Busti F; Campostrini N; Sandri M; Pelucchi S; Westerman M; Ganz T; Nemeth E; Piperno A; Camaschella C
Haematologica; 2011 Apr; 96(4):500-6. PubMed ID: 21173098
[TBL] [Abstract][Full Text] [Related]
42. Population screening for hemochromatosis: a study in 5370 Spanish blood donors.
Sánchez M; Villa M; Ingelmo M; Sanz C; Bruguera M; Ascaso C; Oliva R
J Hepatol; 2003 Jun; 38(6):745-50. PubMed ID: 12763366
[TBL] [Abstract][Full Text] [Related]
43. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic.
Beutler E; Felitti V; Gelbart T; Ho N
Ann Intern Med; 2000 Sep; 133(5):329-37. PubMed ID: 10979877
[TBL] [Abstract][Full Text] [Related]
44. Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS study.
Barton JC; Leiendecker-Foster C; Reboussin DM; Adams PC; Acton RT; Eckfeldt JH;
Thyroid; 2008 Aug; 18(8):831-8. PubMed ID: 18651828
[TBL] [Abstract][Full Text] [Related]
45. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
[TBL] [Abstract][Full Text] [Related]
46. Mixture models of serum iron measures in population screening for hemochromatosis and iron overload.
McLaren CE; Li KT; McLaren GD; Gordeuk VR; Snively BM; Reboussin DM; Barton JC; Acton RT; Dawkins FW; Harris EL; Eckfeldt JH; Moses GC; Adams PC
Transl Res; 2006 Oct; 148(4):196-206. PubMed ID: 17002922
[TBL] [Abstract][Full Text] [Related]
47. [HFE hemochromatosis: pathogenic and diagnostic approach].
Brissot P; Le Lan C; Troadec MB; Lorho R; Ropert M; Lescoat G; Loréal O
Transfus Clin Biol; 2005 Jun; 12(2):77-82. PubMed ID: 15925529
[TBL] [Abstract][Full Text] [Related]
48. HFE-associated hereditary hemochromatosis.
Alexander J; Kowdley KV
Genet Med; 2009 May; 11(5):307-13. PubMed ID: 19444013
[TBL] [Abstract][Full Text] [Related]
49. African Americans at risk for increased iron stores or liver disease.
Dawkins FW; Gordeuk VR; Snively BM; Lovato L; Barton JC; Acton RT; McLaren GD; Leiendecker-Foster C; McLaren CE; Adams PC; Speechley M; Harris EL; Jackson S; Thomson EJ
Am J Med; 2007 Aug; 120(8):734.e1-9. PubMed ID: 17679134
[TBL] [Abstract][Full Text] [Related]
50. Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis.
Hunt JR; Zeng H
Am J Clin Nutr; 2004 Oct; 80(4):924-31. PubMed ID: 15447900
[TBL] [Abstract][Full Text] [Related]
51. Liver diseases in the hemochromatosis and iron overload screening study.
Adams PC; Passmore L; Chakrabarti S; Reboussin DM; Acton RT; Barton JC; McLaren GD; Eckfeldt JH; Dawkins FW; Gordeuk VR; Harris EL; Leiendecker-Foster C; Gossman E; Sholinsky P;
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):918-23; quiz 807. PubMed ID: 16797244
[TBL] [Abstract][Full Text] [Related]
52. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.
Desgrippes R; Lainé F; Morcet J; Perrin M; Manet G; Jezequel C; Bardou-Jacquet E; Ropert M; Deugnier Y
Hepatology; 2013 May; 57(5):1784-92. PubMed ID: 23322654
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
Byrnes V; Ryan E; O'Keane C; Crowe J
Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
[TBL] [Abstract][Full Text] [Related]
54. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.
Phatak PD; Ryan DH; Cappuccio J; Oakes D; Braggins C; Provenzano K; Eberly S; Sham RL
Blood Cells Mol Dis; 2002; 29(1):41-7. PubMed ID: 12482402
[TBL] [Abstract][Full Text] [Related]
55. Asymptomatic hemochromatosis subjects: genotypic and phenotypic profiles.
Sham RL; Raubertas RF; Braggins C; Cappuccio J; Gallagher M; Phatak PD
Blood; 2000 Dec; 96(12):3707-11. PubMed ID: 11090050
[TBL] [Abstract][Full Text] [Related]
56. Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study.
Adams PC; Reboussin DM; Leiendecker-Foster C; Moses GC; McLaren GD; McLaren CE; Dawkins FW; Kasvosve I; Acton RT; Barton JC; Zaccaro D; Harris EL; Press R; Chang H; Eckfeldt JH
Clin Chem; 2005 Jun; 51(6):1048-52. PubMed ID: 15833784
[No Abstract] [Full Text] [Related]
57. Hereditary hemochromatosis.
Crownover BK; Covey CJ
Am Fam Physician; 2013 Feb; 87(3):183-90. PubMed ID: 23418762
[TBL] [Abstract][Full Text] [Related]
58. HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study.
Pankow JS; Boerwinkle E; Adams PC; Guallar E; Leiendecker-Foster C; Rogowski J; Eckfeldt JH
Transl Res; 2008 Jul; 152(1):3-10. PubMed ID: 18593631
[TBL] [Abstract][Full Text] [Related]
59. The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene.
Silva B; Pita L; Gomes S; Gonçalves J; Faustino P
Ann Hematol; 2014 Dec; 93(12):2063-6. PubMed ID: 25015054
[TBL] [Abstract][Full Text] [Related]
60. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Barton JC; Wiener HW; Acton RT; Go RC
Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
